Correlation Between Pacira BioSciences, and Shuttle Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pacira BioSciences, and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Pacira BioSciences, and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Shuttle Pharmaceuticals.

Diversification Opportunities for Pacira BioSciences, and Shuttle Pharmaceuticals

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pacira and Shuttle is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Pacira BioSciences, and Shuttle Pharmaceuticals

Given the investment horizon of 90 days Pacira BioSciences, is expected to generate 0.47 times more return on investment than Shuttle Pharmaceuticals. However, Pacira BioSciences, is 2.15 times less risky than Shuttle Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.74 per unit of risk. If you would invest  1,687  in Pacira BioSciences, on August 31, 2024 and sell it today you would lose (23.00) from holding Pacira BioSciences, or give up 1.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pacira BioSciences,  vs.  Shuttle Pharmaceuticals

 Performance 
       Timeline  
Pacira BioSciences, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pacira BioSciences, and Shuttle Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pacira BioSciences, and Shuttle Pharmaceuticals

The main advantage of trading using opposite Pacira BioSciences, and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.
The idea behind Pacira BioSciences, and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities